| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -16 | 96 | 1.18 | 0.01 | BLENDED GS |
| May 2025 | 37 | 97 | -1.48 | 1.46 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -16 | 96 | 1.18 | 0.01 | BLENDED GS |
| May 2025 | 37 | 97 | -1.48 | 1.46 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 3894 | 695 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 695 | 3894 | 122840 | 380 | 380 | 87 | 87 |
| May 2025 | 694 | 3890 | 120404 | 379 | 379 | 88 | 87 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 695 | 3894 | 122840 | 380 | 380 | 87 | 87 |
| May 2025 | 694 | 3890 | 120404 | 379 | 379 | 88 | 87 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 3831 | 3376 | 2833 | 2138 | 1346 |
| No. Herds | 642 | 644 | 619 | 524 | 398 |
| No. without completed record | 13 | 25 | 70 | 281 | 332 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 3831 | 3376 | 2833 | 2138 | 1346 |
| No. Herds | 642 | 644 | 619 | 524 | 398 |
| No. without completed record | 13 | 25 | 70 | 281 | 332 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 3894 | 695 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | ||||
| CAN | ||||
| DFS | ||||
| FRA | ||||
| GBR | ||||
| GER | ||||
| ITA | ||||
| NLD | ||||
| NZL | ||||
| USA | ||||